Barclays »

Clearside Biomedical shares owned by Barclays

Quarter-by-quarter ownership of Clearside Biomedical shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Clearside Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Clearside Biomedical held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Clearside Biomedical by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $56 14 4.00

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Clearside Biomedical

Geode Capital Management
BlackRock
Renaissance Technologies
First Manhattan
State Street Corporation
GSA Capital Partners
Northern Trust
Pnc Financial Services
New Millennium Group
Wells Fargo & Company
FMR
Atlantic Trust
SBI Securities
Jpmorgan Chase & Co
Barclays

View all funds holding Clearside Biomedical